Related Experiment Video
Updated: Jun 20, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Current perspectives in prostate cancer vaccines
Philip M Arlen1, James L Gulley
1Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1750, USA.
Cancer vaccines are a promising therapeutic approach. This review highlights new vaccines and strategies for treating prostate cancer, leveraging its unique characteristics for effective immunotherapy.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Cancer vaccines are being explored as a therapeutic option.
- Advances include tumor antigen identification, new delivery systems, and combination therapies.
- Prostate cancer is a suitable target for immunotherapy due to its slow growth and specific antigens.
Purpose of the Study:
- To review novel vaccines for cancer treatment.
- To discuss new perspectives in prostate cancer immunotherapy.
Main Methods:
- Literature review of recent advances in cancer vaccines.
- Focus on immunotherapy for prostate cancer.
Main Results:
- Identification of tumor-associated antigens.
- Development of novel vaccine delivery systems.
- Combination of vaccines with immune stimulants and other therapies.
Conclusions:
- Prostate cancer is an ideal target for immunotherapy.
- New vaccines and therapeutic strategies show promise for prostate cancer treatment.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics

